Skip to main content
logo
Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.030
+0.032 (3.17%)
At close: Sep 17, 2026, 4:00 PM EDT
1.040
+0.010 (0.97%)
After-hours: Sep 17, 2026, 7:57 PM EDT

Ocugen Revenue

Ocugen had revenue of $1.49M in the quarter ending June 30, 2026, with 8.38% growth. This brings the company's revenue in the last twelve months to $4.58M, down -3.66% year-over-year. In the year 2025, Ocugen had annual revenue of $4.41M with 8.83% growth.

Revenue (ttm)
$4.58M
Revenue Growth
-3.66%
P/S Ratio
76.25
Revenue / Employee
$39,491
Employees
116
Market Cap
349.28M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.41M358.00K8.83%
Dec 31, 20244.06M-1.98M-32.82%
Dec 31, 20236.04M3.55M142.60%
Dec 31, 20222.49M--
Dec 31, 2021---
Dec 31, 202043.00K--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 20138.00K-18.00K-69.23%
Dec 31, 201226.00K-97.00K-78.86%
Dec 31, 2011123.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Agenus132.69M
Century Therapeutics109.16M
Enanta Pharmaceuticals65.26M
Q32 Bio53.74M
X4 Pharmaceuticals15.85M
Evommune10.00M
EyePoint2.79M
Compass Therapeutics850.00K
Revenue Rankings

OCGN News

More News